Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
Xeriant Inc. (XERI) Builds Innovation Ecosystem Focused on Advanced Technologies, Commercialization
Xeriant is focused on acquiring, developing and commercializing transformative technologies with applications across multiple industrial…
-
TechForce Robotics Inc. (NGTF): Proving Practical Solutions for the Industry’s Fatigued Areas
Hospitality operators are adopting robotics to target the most physically demanding jobs in hotels, venues,…
-
Drilling Assay Results Boost Deposit Potential, Demonstrates High-Grade Gold Intervals and Continuity for LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF), Setting Stage for Forthcoming PEA
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may…